Research ExplorerPublicationsSelective serotonin reuptake inhibitors and tricyclic antide...

Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.

Standard

Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. / von Wolff, Alessa; Hölzel, L P; Westphal, Annika; Härter, Martin; Kriston, Levente.

In: J AFFECT DISORDERS, Vol. 144, No. 1-2, 1-2, 2013, p. 7-15.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

von Wolff, A, Hölzel, LP, Westphal, A, Härter, M & Kriston, L 2013, 'Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.', J AFFECT DISORDERS, vol. 144, no. 1-2, 1-2, pp. 7-15. <http://www.ncbi.nlm.nih.gov/pubmed/22963896?dopt=Citation>

APA

von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M., & Kriston, L. (2013). Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J AFFECT DISORDERS, 144(1-2), 7-15. [1-2]. http://www.ncbi.nlm.nih.gov/pubmed/22963896?dopt=Citation

Vancouver

von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J AFFECT DISORDERS. 2013;144(1-2):7-15. 1-2.

Bibtex

@article{149a7a270daa496fa72270b2da63a3b7,
title = "Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.",
abstract = "Chronic depression represents a substantial portion of depressive disorders and is associated with severe consequences. This review examined the efficacy and acceptability of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) in the treatment of chronic depression. Additionally, the comparative effectiveness of the two types of antidepressants has been examined.",
author = "{von Wolff}, Alessa and H{\"o}lzel, {L P} and Annika Westphal and Martin H{\"a}rter and Levente Kriston",
year = "2013",
language = "English",
volume = "144",
pages = "7--15",
journal = "J AFFECT DISORDERS",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-2",

}

RIS

TY - JOUR

T1 - Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.

AU - von Wolff, Alessa

AU - Hölzel, L P

AU - Westphal, Annika

AU - Härter, Martin

AU - Kriston, Levente

PY - 2013

Y1 - 2013

N2 - Chronic depression represents a substantial portion of depressive disorders and is associated with severe consequences. This review examined the efficacy and acceptability of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) in the treatment of chronic depression. Additionally, the comparative effectiveness of the two types of antidepressants has been examined.

AB - Chronic depression represents a substantial portion of depressive disorders and is associated with severe consequences. This review examined the efficacy and acceptability of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) in the treatment of chronic depression. Additionally, the comparative effectiveness of the two types of antidepressants has been examined.

M3 - SCORING: Journal article

VL - 144

SP - 7

EP - 15

JO - J AFFECT DISORDERS

JF - J AFFECT DISORDERS

SN - 0165-0327

IS - 1-2

M1 - 1-2

ER -